Aclarion, Inc. ( (ACON) ) just unveiled an update. Aclarion, Inc. announced the pricing of a registered direct offering of ...
Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
ACON Stock Performance and Moving Averages. In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating 26.02% over the last five trades and -19.60% ...
Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
Aclarion, Inc. announced the termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC effective immediately. This decision halts the company’s ability to sell ...
Aclarion, Inc. (NASDAQ:ACON – Get Free Report) saw a large growth in short interest during the month of December. As of ...
EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market 03.01.2025 / 22:15 CET/CEST The issuer is solely ...